StackTerminal.Health

BETA

Stress-Resilient Training Stack

B84· Mostly solid
Public 04 Feb 2026

Supports training consistency under physical & mental stress.

Stress-Resilient Training Stack
Ashwagandha
Daily
MODERATE
600mg
Glycine
Daily
MODERATE
3000mg
No interactions detected
Each dose includes evidence rationale · doses personalized to your weight
Stack note
Private note on this stack

Track how this stack felt, what you want to change next cycle, or anything you want to save privately in your member zone.

Sign in to keep a private note on Stress-Resilient Training Stack.
AI risk assessment
Context: No wearable data
PROAI risk assessment is available with Pro.
See plans
Stack pre-check
No personal data connected — connect wearables or upload bloodwork for a personalised check
Clean
Supplements
2
Training load
Unknown
No flags
No duplication, stimulant, interaction, or recovery concerns detected.

Pre-check is rule-based, not medical advice. Consult a healthcare professional for personalised guidance.

Interaction Analysis
Pharmacokinetic + pair-level checks
Timing optimizations
Ashwagandha
Evening or split morning/evening
Cortisol-lowering adaptogens are best timed to evening to avoid blunting morning cortisol rise. (Onset: ~1.5h, half-life: ~7h)
Glycine
Before bed
Glycine lowers core body temperature and improves slow-wave sleep. 3g ~30–60 min before bed is the studied dose. (Onset: ~30 min, half-life: ~2h)

Interaction analysis is based on peer-reviewed pharmacology. PMID links go to PubMed. Not medical advice.

Supplements
2 items
600mg
Trade-offs & context
Interaction

May elevate thyroid hormones (T3/T4) — caution with thyroid conditions or thyroid medications

Liver

Rare hepatotoxicity cases reported — discontinue if liver enzymes elevated; likely dose- or contaminant-related

Interaction

May potentiate sedatives and anxiolytics — additive CNS depression

Physical performance (strength, VO2max)
Moderate
Population: Healthy adults and athletes
Study type: Systematic review & Bayesian meta-analysis
Dose context: 600 mg typical (range: 300–600 mg) • Duration: 8–12 weeks

Significant improvements in muscle strength, power, & VO2max compared to placebo across 13 RCTs.

Citation: Bonilla DA et al. J Funct Morphol Kinesiol. 2021;6(1):20.https://pubmed.ncbi.nlm.nih.gov/33670194/
Effect sizes moderate; responder variability exists.
Sleep quality / sleep onset latency
Moderate
Population: Adults with and without insomnia
Study type: Systematic review & meta-analysis (5 RCTs, n=400)
Dose context: 600 mg typical (range: 300–600 mg) • Duration: 8–10 weeks

Small but significant improvement in overall sleep (SMD −0.59); stronger effects in insomnia subgroup & at ≥600 mg/day for ≥8 weeks.

Citation: Cheah KL et al. PLoS ONE. 2021;16(9):e0257843.DOI: 10.1371/journal.pone.0257843https://pubmed.ncbi.nlm.nih.gov/34559859/
No serious adverse effects reported in included trials.
Perceived stress & anxiety reduction
Moderate
Population: Adults with insomnia and anxiety
Study type: RCT (double-blind, placebo-controlled)
Dose context: 300 mg typical (range: 300–300 mg) • Duration: 10 weeks

300 mg ashwagandha root extract twice daily significantly improved sleep quality, anxiety scores, & mental alertness on rising vs. placebo.

Citation: Langade D et al. Cureus. 2019;11(9):e5797.DOI: 10.7759/cureus.5797https://pubmed.ncbi.nlm.nih.gov/31728244/
Dose refers to standardized KSM-66 extract. Stress & anxiety benefits seen across multiple RCTs.
GlycineModerate
Daily
3000mg
Daytime sleepiness & performance after sleep restriction
Moderate
Population: Healthy adults with partial sleep restriction
Study type: RCT (double-blind, placebo-controlled, crossover)
Dose context: 3000 mg typical (range: 3000–3000 mg) • Duration: 3 nights

3 g glycine before bed significantly reduced daytime sleepiness, fatigue, & cognitive impairment following 25% sleep restriction; mechanism involves core body temperature reduction via SCN NMDA receptors.

Citation: Bannai M et al. Front Neurol. 2012;3:61.DOI: 10.3389/fneur.2012.00061https://pubmed.ncbi.nlm.nih.gov/22529837/
Well-tolerated at 3 g; higher doses not well-characterized for sleep specifically.
Collagen synthesis / connective tissue support
Moderate
Population: Recreationally active males
Study type: RCT (mechanistic)
Dose context: 15000 mg typical (range: 5000–15000 mg) • Duration: Acute (pre-exercise)

15 g gelatin (rich in glycine & proline, with vitamin C) before intermittent exercise doubled collagen synthesis markers (P1NP) vs. placebo; glycine is the most abundant amino acid in collagen (~33%).

Citation: Shaw G et al. Am J Clin Nutr. 2017;105(1):136–143.DOI: 10.3945/ajcn.116.138594https://pubmed.ncbi.nlm.nih.gov/27852613/
Study used gelatin + vitamin C, not isolated glycine; glycine is rate-limiting for collagen synthesis.

Similar community stacks

Avoid reinventing the wheel: fork a community stack that matches your category tags, then edit it.

Browse all community stacks →
stresscognitivefocus

Combining L-Tyrosine with Eleuthero can reduce stress and support cognitive function. L-Tyrosine is known for its role in stress reduction and cognitive enhancement, while Eleuthero is an adaptogen that supports focus and endurance.

L-Tyrosine
500mg
Eleuthero (Siberian Ginseng)
400mg
New
View
recoveryskinresearch-only

Adds a copper peptide often discussed in cosmetic/skin contexts to a recovery/joint pairing. Evidence is indirect & component-based.

BPC-157
1mg
TB500 (TB4 / Thymosin Beta-4)
1mg
GHK-Cu
1mg
New
View
recoverypeptidestissue-repair

BPC-157 & TB-500 are the two most researched recovery peptides, with complementary mechanisms. BPC-157 (Body Protection Compound) accelerates tendon, ligament, & gut repair via angiogenesis & growth factor upregulation. TB-500 (Thymosin Beta-4) promotes systemic tissue repair, reduces inflammation, & improves mobility. GHK-Cu supports collagen synthesis & skin regeneration. Note: all three are research compounds not approved for human therapeutic use.

BPC-157
0mg
TB500 (TB4 / Thymosin Beta-4)
5mg
GHK-Cu
1mg
New
View